Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.

Kogan SC, Ward JM, Anver MR, Berman JJ, Brayton C, Cardiff RD, Carter JS, de Coronado S, Downing JR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Hiai H, Jaffe ES, MacLennan IC, Pandolfi PP, Pattengale PK, Perkins AS, Simpson RM, Tuttle MS, Wong JF, Morse HC 3rd; Hematopathology subcommittee of the Mouse Models of Human Cancers Consortium.

Blood. 2002 Jul 1;100(1):238-45.

2.

Bethesda proposals for classification of lymphoid neoplasms in mice.

Morse HC 3rd, Anver MR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Jaffe ES, Kogan SC, MacLennan IC, Pattengale PK, Ward JM; Hematopathology subcommittee of the Mouse Models of Human Cancers Consortium.

Blood. 2002 Jul 1;100(1):246-58.

3.

The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.

Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD.

Ann Oncol. 1999 Dec;10(12):1419-32.

4.

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD.

Blood. 2009 Jul 30;114(5):937-51. doi: 10.1182/blood-2009-03-209262. Epub 2009 Apr 8. Review.

5.

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report.

Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK.

Am J Clin Pathol. 1999 Jan;111(1 Suppl 1):S8-12.

6.

The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.

Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD.

Histopathology. 2000 Jan;36(1):69-86.

PMID:
10632755
7.

The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.

Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD.

Mod Pathol. 2000 Feb;13(2):193-207.

8.

The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.

Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD.

Hematol J. 2000;1(1):53-66.

PMID:
11920170
9.

The World Health Organization (WHO) classification of the myeloid neoplasms.

Vardiman JW, Harris NL, Brunning RD.

Blood. 2002 Oct 1;100(7):2292-302. Review.

10.

The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms. An update.

Frizzera G, Wu CD, Inghirami G.

Am J Clin Pathol. 1999 Jan;111(1 Suppl 1):S13-39. Review. No abstract available.

11.

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD.

J Clin Oncol. 1999 Dec;17(12):3835-49.

PMID:
10577857
12.
13.

The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.

Anastasi J.

Hematol Oncol Clin North Am. 2009 Aug;23(4):693-708. doi: 10.1016/j.hoc.2009.04.002. Review.

PMID:
19577165
14.

Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.

Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM, Cardiff RD.

Cancer Res. 2004 Mar 15;64(6):2270-305. Review.

15.

The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats.

Frith CH, Ward JM, Chandra M.

Toxicol Pathol. 1993;21(2):206-18. Review.

16.

Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium.

Nikitin AY, Alcaraz A, Anver MR, Bronson RT, Cardiff RD, Dixon D, Fraire AE, Gabrielson EW, Gunning WT, Haines DC, Kaufman MH, Linnoila RI, Maronpot RR, Rabson AS, Reddick RL, Rehm S, Rozengurt N, Schuller HM, Shmidt EN, Travis WD, Ward JM, Jacks T.

Cancer Res. 2004 Apr 1;64(7):2307-16. Review. Erratum in: Cancer Res. 2004 May 15;64(10):3725.

17.
18.

Philadelphia chromosome-negative chronic myeloproliferative disease.

Thiele J.

Am J Clin Pathol. 2009 Aug;132(2):261-80. doi: 10.1309/AJCPR8GINMBDG9YG. Review.

19.

Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification.

Martín-Subero JI, Gesk S, Harder L, Grote W, Siebert R.

Anticancer Res. 2003 Mar-Apr;23(2A):1139-48. Review.

PMID:
12820362
20.

WHO classification of myeloid neoplasms and leukemia.

Wandt H, Haferlach T, Thiede C, Ehninger G.

Blood. 2010 Jan 21;115(3):748-9; author reply 749-50. doi: 10.1182/blood-2009-10-249664. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk